QA: Organogenesis Holdings Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001661181_2023_Organogenesis_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001661181, Organogenesis Holdings Inc.

  xvar xval
0 AssetsCurrent 222,609,000
1 IntangibleAssetsNetIncludingGoodwill 49,561,000
2 PropertyPlantAndEquipmentNet 102,463,000
3 remainder_Assets 74,726,000
4 LiabilitiesCurrent 75,023,000
5 LiabilitiesNoncurrent 42,436,000
6 remainder_Liabilities 66,231,000
7 CostOfGoodsAndServicesSold 105,019,000
8 SellingGeneralAndAdministrativeExpense 283,808,000
9 ResearchAndDevelopmentExpense 39,762,000
10 remainder_Expenses 4,750,000
11 remainder_Revenues 450,893,000
12 remainder_NetIncome -2,022,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 449,359,000
1 Liabilities 183,690,000
2 Expenses 433,339,000
3 Revenues 450,893,000
4 StockholdersEquity 265,669,000
5 NetIncome 15,532,000
6 ComprehensiveNetIncome 15,532,000
7 BaseVar 759,651,500
8 EconomicCapitalRatio 1.49

Edgar->Model Mapping

Feature Distribution

Change over Time